Macquarie Group’s Fortress Biotech FBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-6,666
| Closed | -$25K | – | 1066 |
|
|
2025
Q3 | $25K | Hold |
6,666
| – | – | ﹤0.01% | 1548 |
|
|
2025
Q2 | $12K | Hold |
6,666
| – | – | ﹤0.01% | 1624 |
|
|
2025
Q1 | $10K | Hold |
6,666
| – | – | ﹤0.01% | 1646 |
|
|
2024
Q4 | $13K | Hold |
6,666
| – | – | ﹤0.01% | 1575 |
|
|
2024
Q3 | $10K | Hold |
6,666
| – | – | ﹤0.01% | 1625 |
|
|
2024
Q2 | $11K | Hold |
6,666
| – | – | ﹤0.01% | 1655 |
|
|
2024
Q1 | $13K | Hold |
6,666
| – | – | ﹤0.01% | 1587 |
|
|
2023
Q4 | $20K | Sell |
6,666
-1
| -0% | -$3 | ﹤0.01% | 1607 |
|
|
2023
Q3 | $29K | Hold |
6,667
| – | – | ﹤0.01% | 1594 |
|
|
2023
Q2 | $55K | Hold |
6,667
| – | – | ﹤0.01% | 1612 |
|
|
2023
Q1 | $82K | Hold |
6,667
| – | – | ﹤0.01% | 1615 |
|
|
2022
Q4 | $66K | Hold |
6,667
| – | – | ﹤0.01% | 1657 |
|
|
2022
Q3 | $86K | Hold |
6,667
| – | – | ﹤0.01% | 1803 |
|
|
2022
Q2 | $84K | Hold |
6,667
| – | – | ﹤0.01% | 1910 |
|
|
2022
Q1 | $136K | Hold |
6,667
| – | – | ﹤0.01% | 1880 |
|
|
2021
Q4 | $250K | Hold |
6,667
| – | – | ﹤0.01% | 1729 |
|
|
2021
Q3 | $322K | Hold |
6,667
| – | – | ﹤0.01% | 1731 |
|
|
2021
Q2 | $357K | Hold |
6,667
| – | – | ﹤0.01% | 1725 |
|
|
2021
Q1 | $353K | Hold |
6,667
| – | – | ﹤0.01% | 1589 |
|
|
2020
Q4 | $317K | Hold |
6,667
| – | – | ﹤0.01% | 1545 |
|
|
2020
Q3 | $404K | Hold |
6,667
| – | – | ﹤0.01% | 1444 |
|
|
2020
Q2 | $268K | Hold |
6,667
| – | – | ﹤0.01% | 1482 |
|
|
2020
Q1 | $189K | Hold |
6,667
| – | – | ﹤0.01% | 1468 |
|
|
2019
Q4 | $257K | Hold |
6,667
| – | – | ﹤0.01% | 1534 |
|
|
2019
Q3 | $141K | Sell |
6,667
-739
| -10% | -$17.4K | ﹤0.01% | 1670 |
|
|
2019
Q2 | $167K | Buy |
+7,406
| New | +$190K | ﹤0.01% | 1621 |
|
|
2019
Q1 | – | Sell |
-2,184
| Closed | -$28K | – | 1776 |
|
|
2018
Q4 | $28K | Sell |
2,184
-1,694
| -44% | -$28.3K | ﹤0.01% | 1713 |
|
|
2018
Q3 | $93K | Sell |
3,878
-2,654
| -41% | -$84.9K | ﹤0.01% | 1604 |
|
|
2018
Q2 | $292K | Buy |
6,532
+3,407
| +109% | +$192K | ﹤0.01% | 1534 |
|
|
2018
Q1 | $213K | Buy |
3,125
+2,845
| +1,016% | +$180K | ﹤0.01% | 1682 |
|
|
2017
Q4 | $17K | Buy |
+280
| New | +$16.5K | ﹤0.01% | 2223 |
|
|
2013
Q4 | – | Sell |
-2,000
| Closed | -$211K | – | 1568 |
|
|
2013
Q3 | $211K | Buy |
2,000
+667
| +50% | +$81.8K | ﹤0.01% | 1408 |
|
|
2013
Q2 | $172K | Buy |
+1,333
| New | +$197K | ﹤0.01% | 1393 |
|
Other funds holding FBIO
OM
SF
SAM
SC
BCM
Macquarie Group's FBIO Position: Q4 2025 in Review
Macquarie Group sold out of Fortress Biotech (FBIO) in Q4 2025, closing a stake of 6,666 shares — an estimated $25K sold.
Macquarie Group first reported a position in FBIO in Q2 2013 and held it in 33 quarters. The position peaked at $404K in Q3 2020. 52 funds tracked by Wall St. Rank hold FBIO as of Q4 2025.
- Macquarie Group reported no remaining Fortress Biotech position as of Q4 2025 after selling out during the quarter.
- Macquarie Group sold 6,666 Fortress Biotech shares in Q4 2025, an estimated $25K.
- Macquarie Group first reported a position in Fortress Biotech in Q2 2013 and held it in 33 quarters.
- Macquarie Group's Fortress Biotech position peaked at $404K in Q3 2020.
- 52 funds tracked by Wall St. Rank held Fortress Biotech as of Q4 2025.
Based on Macquarie Group's 13F filing for Q4 2025, filed 13 Feb 2026.